Europe Gas Exchange Pulmonary Function Testing Market - Industry Trends And Forecast To 2028
- Published Date: 2022-11-21
- Report ID: 144408
- Pages: 200
-
Format:
Short Description
Europe Gas Exchange Pulmonary Function Testing Market, By Test Type (Diffusion Capacity Test and Gas Distribution Test), System Type (Portable and Stationary), Application (Chronic Obstructive Pulmonary, Asthma, Chronic Shortness of Breath, Pulmonary Embolism, Pulmonary Hypertension Sarcoidosis, Interstitial Fibrosis, Restrictive Lung Disease, Lung Haemorrhage, and Others), End User (Hospitals, Specialty Clinics, Diagnostic Laboratories, and Others), Country (Germany, France U.K., Italy, Spain, Russia, Switzerland, Netherland, Turkey, Belgium and Rest of Europe) Industry Trends and Forecast to 2028
Market Definition:
The gas exchange test, or in medical terms called lung diffusion testing, measures how well the lungs exchange gases. This is an important criterion of lung testing because the important role of the lungs is to allow oxygen to diffuse into the blood from the lungs and allow carbon dioxide to pass from the blood into the lungs. The pulmonary function test (PFT) is a non-invasive test that shows the lungs' performing capacity. The tests determine the lung volume, capacity, rates of flow, and gas exchange. The data collected can help the healthcare provider diagnose and adapt the treatment of certain lung diseases. In Europe, pulmonary and respiratory diseases rank second in mortality, incidence, prevalence, and costs. Lung cancer, asthma, and chronic obstructive pulmonary disease (COPD) are the main cause of respiratory causes of death in Western Europe and Central and Eastern Europe. The rise in prevalence of pulmonary diseases in Europe is due to a rise in pollution levels and inhalation of tobacco. Hence, this necessitates the use of gas exchange pulmonary function testing in Europe.
Market Segmentation:
The Europe gas exchange pulmonary function testing market is segmented based on test type, system type, application, and end user.
On the basis of test type, the Europe gas exchange pulmonary function testing market is segmented into diffusion capacity test and gas distribution test
On the basis of system type, the Europe gas exchange pulmonary function testing market is segmented into portable and stationary
On the basis of application, the Europe gas exchange pulmonary function testing market is segmented into chronic obstructive pulmonary, asthma, chronic shortness of breath, restrictive lung disease, interstitial fibrosis, lung hemorrhage, pulmonary embolism, pulmonary hypertension sarcoidosis, and others
On the basis of end user, the Europe gas exchange pulmonary function testing market is segmented into hospitals, specialty clinics, diagnostics laboratories, and others
Market Players
The key market players for the Europe gas exchange pulmonary function testing market are listed below:
VYAIRE
Geratherm Respiratory GmbH (A subsidiary of Geratherm)
M.E.C. MEDICAL ELECTRONIC CONSTRUCTION
ECO MEDICS AG
PulmOne Advanced Medical Devices.
Data Sciences International (A subsidiary of Harvard Bioscience)
medical equipment europe GmbH
NDD Medical Technologies
MGC DIAGNOSTICS CORPORATION. (A subsidiary of ALTUS CAPITAL PARTNERS)
SCHILLER
Medisoft Group
Biodex Medical Systems, Inc. (A subsidiary of MRI Technologies Inc)
COSMED srl
PISTON MEDICAL
CARESTREAM MEDICAL
KoKo PFT
ASI Health Services
Swedish Health Services
Bellin Health Systems
TABLE OF CONTENTS
1 INTRODUCTION 14
1.1 OBJECTIVES OF THE STUDY 14
1.2 MARKET DEFINITION 14
1.3 OVERVIEW OF THE EUROPE GAS EXCHANGE PULMONARY FUNCTION TESTING MARKET 15
1.4 CURRENCY AND PRICING 16
1.5 LIMITATIONS 16
1.6 MARKETS COVERED 17
2 EUROPE GAS EXCHANGE PULMONARY FUNCTION TESTING MARKET: SEGMENTATION 19
2.1 MARKETS COVERED 19
2.2 GEOGRAPHICAL SCOPE 20
2.3 YEARS CONSIDERED FOR THE STUDY 20
2.4 DBMR TRIPOD DATA VALIDATION MODEL 21
2.5 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 24
2.6 MULTIVARIATE MODELLING 25
2.7 TEST TYPE SEGMENT LIFELINE CURVE 25
2.8 DBMR MARKET POSITION GRID 26
2.9 VENDOR SHARE ANALYSIS 27
2.10 MARKET END USER COVERAGE GRID 28
2.11 SECONDARY SOURCES 29
2.12 ASSUMPTIONS 29
3 EXECUTIVE SUMMARY 30
4 PREMIUM INSIGHTS 33
5 PESTEL EUROPE GAS EXCHANGE PULMONARY FUNCTION TESTING MARKET 34
6 PORTER'S FIVE FORCES_EUROPE GAS EXCHANGE PULMONARY FUNCTION TESTING MARKET 35
7 EUROPE GAS EXCHANGE PULMONARY FUNCTION TESTING MARKET: REGULATIONS 36
7.1 GERMANY 36
7.2 FRANCE 36
7.3 U.K. 37
7.4 ITALY 37
7.5 SPAIN 37
7.6 TURKEY 37
7.7 BELGIUM 37
8 MARKET OVERVIEW 38
8.1 DRIVERS 40
8.1.1 THE RISE IN PREVALENCE OF PULMONARY DISEASES IN EUROPE 40
8.1.1.1 RISE IN GERIATRIC POPULATION 41
8.1.2 THE RISE IN AIR POLLUTION LEVELS IN EUROPE 41
8.1.3 THE TECHNOLOGICAL DEVELOPMENTS IN THE GAS EXCHANGE PULMONARY FUNCTION TESTING DEVICES 42
8.1.4 RISE IN PRODUCT LAUNCHES 42
8.2 RESTRAINTS 43
8.2.1 THE HIGH COST ASSOCIATED WITH THE GAS EXCHANGE PULMONARY FUNCTION TESTING DEVICES 43
8.2.2 THE REIMBURSEMENT ISSUES WITH THE USE OF PULMONARY FUNCTION TESTING DEVICES 43
8.2.3 THE RISKS OBSERVED WHILE USING PULMONARY FUNCTION TESTING DEVICES 43
8.2.4 RISE IN PRODUCT RECALL 44
8.3 OPPORTUNITIES 44
8.3.1 THE RISE IN MINIMALLY INVASIVE TESTS TO DEVELOP AN APPROPRIATE METHOD FOR TREATMENT OF PULMONARY DISEASES 44
8.3.2 STRATEGIC INITIATIVES BY MARKET PLAYERS 45
8.3.3 RISE IN HEALTHCARE EXPENDITURE IN EUROPE 45
8.4 CHALLENGES 46
8.4.1 THE SHORTAGE OF SKILLED PROFESSIONALS IN EUROPE 46
8.4.2 LATE APPROVAL ASSOCIATED WITH PRODUCT LAUNCHES 46
9 IMPACT OF COVID-19 ON EUROPE GAS EXCHANGE PULMONARY FUNCTION TEST MARKET 47
9.1 IMPACT ON PRICE 47
9.2 IMPACT ON DEMAND 47
9.3 IMPACT ON SUPPLY CHAIN 48
9.4 STRATEGIC DECISIONS BY MANUFACTURERS 48
9.5 CONCLUSION 48
10 EUROPE GAS EXCHANGE PULMONARY FUNCTION TESTING MARKET, BY TEST TYPE 50
10.1 OVERVIEW 51
10.2 DIFFUSION CAPACITY TEST 54
10.3 GAS DISTRIBUTION TEST 54
10.3.1 SINGLE BREATH N2 TEST 55
10.3.2 MULTIPLE BREATH N2 TEST 55
10.3.3 HELIUM DILUTION METHOD 55
10.3.4 RADIO XE SCINTIGRAM 55
11 EUROPE GAS EXCHANGE PULMONARY FUNCTION TESTING MARKET, BY SYSTEM TYPE 56
11.1 OVERVIEW 57
11.2 PORTABLE 60
11.3 STATIONARY 60
12 EUROPE GAS EXCHANGE PULMONARY FUNCTION TESTING MARKET, BY APPLICATION 61
12.1 OVERVIEW 62
12.2 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 65
12.3 ASTHMA 65
12.4 CHRONIC SHORTNESS OF BREATH 65
12.5 PULMONARY EMBOLISM 66
12.6 PULMONARY HYPERTENSION SARCOIDOSIS 66
12.7 INTERSTITIAL FIBROSIS 66
12.8 RESTRICTIVE LUNG DISEASE 67
12.9 LUNG HEMORRHAGE 67
12.10 OTHERS 67
13 EUROPE GAS EXCHANGE PULMONARY FUNCTION TESTING MARKET, BY END USER 68
13.1 OVERVIEW 69
13.2 HOSPITALS 72
13.3 SPECIALITY CLINICS 72
13.4 DIAGNOSTIC LABORATORIES 72
13.5 OTHERS 73
14 EUROPE GAS EXCHANGE PULMONARY FUNCTION TESTING MARKET, BY COUNTRY 74
14.1 GERMANY 80
14.2 FRANCE 82
14.3 U.K. 84
14.4 ITALY 86
14.5 SPAIN 88
14.6 RUSSIA 90
14.7 SWITZERLAND 92
14.8 NETHERLANDS 94
14.9 TURKEY 96
14.10 BELGIUM 98
14.11 REST OF EUROPE 100
15 EUROPE GAS EXCHANGE PULMONARY FUNCTION TESTING MARKET COMPANY LANDSCAPE 101
15.1 COMPANY SHARE ANALYSIS: EUROPE 101
16 SWOT ANALYSIS 102
17 COMPANY PROFILE 103
17.1 VYAIRE 103
17.1.1 COMPANY SNAPSHOT 103
17.1.2 1.1.2 PRODUCT PORTFOLIO 103
17.1.3 RECENT DEVELOPMENTS 104
17.2 GERATHERM RESPIRATORY GMBH (A SUBSIDIARY OF GERATHERM) (2020) 105
17.2.1 COMPANY SNAPSHOT 105
17.2.2 REVENUE ANALYSIS 105
17.2.3 PRODUCT PORTFOLIO 106
17.2.4 RECENT DEVELOPMENT 106
17.3 M.E.C. MEDICAL ELECTRONIC CONSTRUCTION 107
17.3.1 COMPANY SNAPSHOT 107
17.3.2 PRODUCT PORTFOLIO 107
17.3.3 RECENT DEVELOPMENTS 107
17.4 ECO MEDICS AG 108
17.4.1 COMPANY SNAPSHOT 108
17.4.2 PRODUCT PORTFOLIO 108
17.4.3 RECENT DEVELOPMENTS 109
17.5 PULMONE ADVANCED MEDICAL DEVICES. 110
17.5.1 COMPANY SNAPSHOT 110
17.5.2 PRODUCT PORTFOLIO 110
17.5.3 RECENT DEVELOPMENTS 110
17.6 ASI HEALTH SERVICES 111
17.6.1 COMPANY SNAPSHOT 111
17.6.2 PRODUCT PORTFOLIO 111
17.6.3 RECENT DEVELOPMENTS 111
17.7 BIODEX MEDICAL SYSTEMS, INC.(A SUBSIDIARY OF MIRION TECHNOLOGIES INC) 112
17.7.1 COMPANY SNAPSHOT 112
17.7.2 PRODUCT PORTFOLIO 112
17.7.3 RECENT DEVELOPMENT 112
17.8 BELLIN HEALTH SYSTEMS 113
17.8.1 COMPANY SNAPSHOT 113
17.8.2 PRODUCT PORTFOLIO 113
17.8.3 RECENT DEVELOPMENT 113
17.9 COSMED SRL 114
17.9.1 COMPANY SNAPSHOT 114
17.9.2 PRODUCT MAPPING 114
17.9.3 RECENT DEVELOPMENTS 114
17.10 CARESTREAM MEDICAL 116
17.10.1 COMPANY SNAPSHOT 116
17.10.2 PRODUCT PORTFOLIO 116
17.10.3 RECENT DEVELOPMENTS 116
17.11 DATA SCIENCE INTERNATIONAL (A SUBSIDIARY OF HARVARD BIOSCIENCE) 117
17.11.1 COMPANY SNAPSHOT 117
17.11.2 REVENUE ANALYSIS 117
17.11.3 PRODUCT PORTFOLIO 118
17.11.4 RECENT DEVELOPMENTS 118
17.12 KOKO PFT 119
17.12.1 COMPANY SNAPSHOT 119
17.12.2 PRODUCT PORTFOLIO 119
17.12.3 RECENT DEVELOPMENT 119
17.13 MEDISOFT ( A SUBSIDIARY OF MGC DIAGNOSTICS CORPORATION) 120
17.13.1 COMPANY SNAPSHOT 120
17.13.2 PRODUCT PORTFOLIO 120
17.13.3 RECENT DEVELOPMENT 120
17.14 MEDICAL EQUIPMENT EUROPE GMBH 121
17.14.1 COMPANY SNAPSHOT 121
17.14.2 PRODUCT PORTFOLIO 121
17.14.3 RECENT DEVELOPMENTS 121
17.15 MGC DIAGNOSTICS CORPORATION. (A SUBSIDIARY OF ALTUS CAPITAL PARTNERS) 122
17.15.1 COMPANY SNAPSHOT 122
17.15.2 PRODUCT PORTFOLIO 122
17.15.3 RECENT DEVELOPMENT 122
17.16 NDD MEDICAL TECHNOLOGIES 123
17.16.1 COMPANY SNAPSHOT 123
17.16.2 PRODUCT PORTFOLIO 123
17.16.3 RECENT DEVELOPMENTS 124
17.17 PISTON MEDICAL 125
17.17.1 COMPANY SNAPSHOT 125
17.17.2 PRODUCT PORTFOLIO 125
17.17.3 RECENT DEVELOPMENT 125
17.18 SWEDISH HEALTH SERVICES 126
17.18.1 COMPANY SNAPSHOT 126
17.18.2 PRODUCT PORTFOLIO 126
17.18.3 RECENT DEVELOPMENT 126
17.19 SCHILLER 127
17.19.1 COMPANY SNAPSHOT 127
17.19.2 PRODUCT PORTFOLIO 127
17.19.3 RECENT DEVELOPMENT 127
18 QUESTIONNAIRE 128
19 RELATED REPORTS 131
Call Us
( India toll free )
+91 835 605 0278
( US toll free )
+1 800 601 6071
Drop us an email at
sales@prudentmarkets.com
Get your pre and post sales queries resolved by our Subject matter experts.
We will assist you to customize the report to fit your research needs.
Our prime focus is to provide qualitative and accurate data.
Feel free to order a sample report before purchase.
Your personal and confidential information is safe and secured.
